دنف (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "دنف" in Arabic language version.

refsWebsite
Global rank Arabic rank
4th place
6th place
1st place
1st place
6th place
3rd place
5th place
4th place
43rd place
2nd place
234th place
251st place
1,169th place
378th place
2nd place
5th place
325th place
30th place
222nd place
221st place
low place
low place
1,775th place
8,272nd place
7,244th place
low place
3,046th place
4,781st place
149th place
233rd place
8,255th place
low place
9,469th place
3,305th place
218th place
222nd place

ahrq.gov

hcup-us.ahrq.gov

archive.org

cdc.gov

doi.org

  • Dewey، A؛ Baughan, C؛ Dean, T؛ Higgins, B؛ Johnson, I (24 يناير 2007). "Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia". The Cochrane database of systematic reviews ع. 1: CD004597. DOI:10.1002/14651858.CD004597.pub2. PMID:17253515.
  • Ries، A؛ Trottenberg, P؛ Elsner, F؛ Stiel, S؛ Haugen, D؛ Kaasa, S؛ Radbruch, L (يونيو 2012). "A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project". Palliative medicine. ج. 26 ع. 4: 294–304. DOI:10.1177/0269216311418709. PMID:21865295.

epcrc.org

hawaii.gov

health.hawaii.gov

maine.gov

medicalxpress.com

nature.com

nih.gov

ncbi.nlm.nih.gov

  • Meresse, B; Ripoche, J; Heyman, M; Cerf-Bensussan, N (October 2008). "Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis". Mucosal Immunology. 2: 8–23. doi:10.1038/mi.2008.75. ببمد19079330. Retrieved 2016-03-30. "نسخة مؤرشفة". مؤرشف من الأصل في 2017-02-25. اطلع عليه بتاريخ 2017-01-11.{{استشهاد ويب}}: صيانة الاستشهاد: BOT: original URL status unknown (link)
  • Lainscak M, Podbregar M, Anker SD (December 2007). "How does cachexia influence survival in cancer, heart failure and other chronic diseases?". Current Opinion in Supportive and Palliative Care. 1 (4): 299–305. doi:10.1097/SPC.0b013e3282f31667. ببمد18685379
  • Bossola M, Pacelli F, Doglietto GB (August 2007). "Novel treatments for cancer cachexia". Expert Opin Investig Drugs. 16 (8): 1241–53. doi:10.1517/13543784.16.8.1241. ببمد17685872. "نسخة مؤرشفة". مؤرشف من الأصل في 2017-02-25. اطلع عليه بتاريخ 2017-01-11.{{استشهاد ويب}}: صيانة الاستشهاد: BOT: original URL status unknown (link)
  • Bossola M, Pacelli F, Doglietto GB (August 2007). "Novel treatments for cancer cachexia". Expert Opin Investig Drugs. 16 (8): 1241–53. doi:10.1517/13543784.16.8.1241. ببمد17685872. ^ تعدى إلى الأعلى ل: a b c d
  • Payne, C; Wiffen, PJ; Martin, S (Jan 18, 2012). "Interventions for fatigue and weight loss in adults with advanced progressive illness.". The Cochrane database of systematic reviews. 1: CD008427. doi:10.1002/14651858.cd008427.pub2. ببمد22258985. تعدى المحتوى الحالي إلى أعلى الصفحة ^
  • K.C.H. Fearon; et al. (Sep 2002). "Cancer cachexia". Int J Cardiol. 85 (1): 73–81. doi:10.1016/S0167-5273(02)00235-8. ببمد12163211. تعدى المحتوى الحالي إلى أعلى الصفحة ^
  • Garcia J.M.; Garcia-Touza M.; Hijazi R.A.; Taffet G.; Epner D.; Mann D.; Smith R.G.; Cunningham G.R.; Marcelli M. (May 2005). "Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia". J. Clin. Endocrinol. Metab. 90 (5): 2920–6. doi:10.1210/jc.2004-1788. ببمد15713718. تعدى المحتوى الحالي إلى أعلى الصفحة ^
  • Brioche T, Pagano AF, Py G, Chopard A (April 2016). "Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention". Mol. Aspects Med. doi:10.1016/j.mam.2016.04.006. ببمد27106402. In conclusion, HMB treatment clearly appears to be a safe potent strategy against sarcopenia, and more generally against muscle wasting, because HMB improves muscle mass, muscle strength, and physical performance. It seems that HMB is able to act on three of the four major mechanisms involved in muscle deconditioning (protein turnover, apoptosis, and the regenerative process), whereas it is hypothesized to strongly affect the fourth (mitochondrial dynamics and functions). Moreover, HMB is cheap (~30– 50 US dollars per month at 3 g per day) and may prevent osteopenia (Bruckbauer and Zemel, 2013; Tatara, 2009; Tatara et al., 2007, 2008, 2012) and decrease cardiovascular risks (Nissen et al., 2000). For all these reasons, HMB should be routinely used in muscle-wasting conditions especially in aged people. ... 3 g of CaHMB taken three times a day (1 g each time) is the optimal posology, which allows for continual bioavailability of HMB in the body (Wilson et al., 2013). ^ تعدى إلى الأعلى ل: a b
  • Argilés JM, Campos N, Lopez-Pedrosa JM, Rueda R, Rodriguez-Mañas L (June 2016). "Skeletal Muscle Regulates Metabolism via Interorgan Crosstalk: Roles in Health and Disease". J. Am. Med. Dir. Assoc. doi:10.1016/j.jamda.2016.04.019. ببمد27324808. Studies suggest dietary protein and leucine or its metabolite b-hydroxy b-methylbutyrate (HMB) can improve muscle function, in turn improving functional performance. ... These have identified the leucine metabolite β-hydroxy β-methylbutyrate (HMB) as a potent stimulator of protein synthesis as well as an inhibitor of protein breakdown in the extreme case of cachexia.65, 72, 76, 77, 78, 79, 80, 81, 82, 83, 84 A growing body of evidence suggests HMB may help slow, or even reverse, the muscle loss experienced in sarcopenia and improve measures of muscle strength.44, 65, 72, 76, 77, 78, 79, 80, 81, 82, 83, 84 However, dietary leucine does not provide a large amount of HMB: only a small portion, as little as 5%, of catabolized leucine is metabolized into HMB.85 Thus, although dietary leucine itself can lead to a modest stimulation of protein synthesis by producing a small amount of HMB, direct ingestion of HMB more potently affects such signaling, resulting in demonstrable muscle mass accretion.71, 80 Indeed, a vast number of studies have found that supplementation of HMB to the diet may reverse some of the muscle loss seen in sarcopenia and in hypercatabolic disease.65, 72, 83, 86, 87 The overall treatment of muscle atrophy should include dietary supplementation with HMB, although the optimal dosage for each condition is still under investigation.68 ... Figure 4: Treatments for sarcopenia. It is currently recommended that patients at risk of or suffering from sarcopenia consume a diet high in protein, engage in resistance exercise, and take supplements of the leucine metabolite HMB.
  • Mullin GE (February 2014). "Nutrition supplements for athletes: potential application to malnutrition". Nutr. Clin. Pract. 29 (1): 146–147. doi:10.1177/0884533613516130. ببمد24336486. There are a number of nutrition products on the market that are touted to improve sports performance. HMB appears to be the most promising and to have clinical applications to improve muscle mass and function. Continued research using this nutraceutical to prevent and/or improve malnutrition in the setting of muscle wasting is warranted. ^ تعدى إلى الأعلى ل: a b c d e f g h i
  • Gagnon B, Bruera E (May 1998). "A review of the drug treatment of cachexia associated with cancer". Drugs. 55 (5): 675–88. doi:10.2165/00003495-199855050-00005. ببمد9585863. تعدى المحتوى الحالي إلى أعلى الصفحة ^
  • Suzuki, H; Asakawa, A; Amitani, H; Nakamura, N; Inui, A (May 2013). "Cancer cachexia--pathophysiology and management.". Journal of gastroenterology. 48 (5): 574–94. doi:10.1007/s00535-013-0787-0. PMC 3698426Freely accessible. ببمد23512346. تعدى المحتوى الحالي إلى أعلى الصفحة ^ نسخة محفوظة 17 يونيو 2018 على موقع واي باك مشين.
  • Yavuzsen T.; Davis M.P.; Walsh D.; LeGrand S.; Lagman R. (November 2005). "Systematic review of the treatment of cancer-associated anorexia and weight loss". J. Clin. Oncol. 23 (33): 8500–11. doi:10.1200/JCO.2005.01.8010. ببمد16293879. تعدى المحتوى الحالي إلى أعلى الصفحة ^
  • J.M. Argilés; et al. (Sep 2011). "Anti-inflammatory therapies in cancer cachexia". Eur J Pharmacol. 668: S81–6. doi:10.1016/j.ejphar.2011.07.007. ببمد21835173. تعدى المحتوى الحالي إلى أعلى الصفحة ^ "نسخة مؤرشفة". مؤرشف من الأصل في 2015-09-24. اطلع عليه بتاريخ 2017-01-11.{{استشهاد ويب}}: صيانة الاستشهاد: BOT: original URL status unknown (link)
  • May, PE; Barber, A; D'Olimpio, JT; Hourihane, A; Abumrad, NN (April 2002). "Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine.". American journal of surgery. 183 (4): 471–9. doi:10.1016/s0002-9610(02)00823-1. ببمد11975938. تعدى المحتوى الحالي إلى أعلى الصفحة ^

pubmed.ncbi.nlm.nih.gov

  • Dewey، A؛ Baughan, C؛ Dean, T؛ Higgins, B؛ Johnson, I (24 يناير 2007). "Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia". The Cochrane database of systematic reviews ع. 1: CD004597. DOI:10.1002/14651858.CD004597.pub2. PMID:17253515.
  • Ries، A؛ Trottenberg, P؛ Elsner, F؛ Stiel, S؛ Haugen, D؛ Kaasa, S؛ Radbruch, L (يونيو 2012). "A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project". Palliative medicine. ج. 26 ع. 4: 294–304. DOI:10.1177/0269216311418709. PMID:21865295.

ny.gov

health.ny.gov

openlibrary.org

  • منير البعلبكي؛ رمزي البعلبكي (2008). المورد الحديث: قاموس إنكليزي عربي (بالعربية والإنجليزية) (ط. 1). بيروت: دار العلم للملايين. ص. 178. ISBN:978-9953-63-541-5. OCLC:405515532. OL:50197876M. QID:Q112315598.

sciencedirect.com

web.archive.org

webmd.com

wikidata.org

wiley.com

onlinelibrary.wiley.com

worldcat.org